Anti-androgens for the treatment of metastatic castration-sensitive prostate cancer

摘要

4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]- Described herein are methods of treating metastatic castration-sensitive prostate cancer with an anti-androgen, including but not limited to 2-fluoro-N-methylbenzamide.